Correction
==========

Following publication of our article \[[@B1]\], the authors noticed that the data incorporated into Figure 4f ([1](#F1){ref-type="fig"}) was incorrect. The first column should be changed from 44, 13 and 46 to read 43, 13 and 44 instead. A corrected version of Figure 4f ([1](#F1){ref-type="fig"}) can be found overleaf.

![**Mdm2 knockdown in estrogen-treated MCF-7 cells inhibits cell proliferation**. Clonal MCF-7 cell lines with *mdm2*shRNA or control vector were treated with 2 μg/ml doxycycline (DOX) for three days to induce shRNA expression, followed by 10 nM estrogen (E2) for five days in the presence of DOX. **(a)**Western blot analysis of Mdm2, p53, p21 and Actin protein levels from whole cell lysates. **(b)**Number of cells was determined by Guava Viacount assay. 10,000 cells were seeded at beginning of treatments. **(c)**Fluorescence activated cell sorting (FACS). Cells were harvested, fixed in 30% ethanol, and cellular DNA was stained with propidium iodide. **(d)**Western blot analysis of Bcl-2 and Actin protein levels from whole cell lysates. **(e)**MCF-7 cells, grown in matrigel for three weeks, formed mass structures of three sizes: large, intermediate and small. **(f)**MCF-7 cells, grown in matrigel for three weeks in the presence of 10 nM estrogen and in the absence or presence of 2 μg/ml doxycycline, were fixed and stained with propidium iodide. Masses of different sizes (large, intermediate and small) were counted and presented as percent of the total population. On average, a total of 300 masses were counted. Averages of three independent experiments are shown. The significance in the percent change of large and small masses was determined by the Student t-test (*P*\< 0.05).](bcr3130-1){#F1}
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